Activity — Hyep Ivan
15 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Sell | BCAX Bicara Therapeutics Inc. Common Stock | $246.9K | -14K -8.53% | 145,355 0.22% of shares | medium |
| Mar 23, 2026 | Sell | BCAX Bicara Therapeutics Inc. Common Stock | $170.3K | -9K -5.95% | 145,355 0.22% of shares | medium |
| Mar 4, 2026 | Sell | BCAX Bicara Therapeutics Inc. Common Stock | $54.1K | -3K -2.00% | 145,355 0.22% of shares | low |
| Mar 23, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Common Stock | $34.9K | +9K +6.33% | 154,555 0.23% of shares | low |
| Jan 22, 2026 | Sell | BCAX Bicara Therapeutics Inc. Common Stock | $34.2K | -2K -1.28% | 145,355 0.22% of shares | low |
| Mar 3, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Common Stock | $27.7K | +7K +5.03% | 152,673 0.23% of shares | low |
| Mar 3, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Common Stock | $23.6K | +6K +4.09% | 158,910 0.24% of shares | low |
| Mar 4, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Common Stock | $11.2K | +3K +2.04% | 148,318 0.22% of shares | low |
| Jan 22, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Common Stock | $7.1K | +2K +1.29% | 147,237 0.22% of shares | low |
| Mar 23, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | -9K -15.82% | 48,944 0.07% of shares | low |
| Mar 4, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | -3K -3.58% | 79,784 0.12% of shares | low |
| Mar 3, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | -6K -7.01% | 82,747 0.13% of shares | low |
| Mar 3, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | -7K -11.18% | 58,144 0.09% of shares | low |
| Feb 2, 2026 | Grant | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | +125K | 125,000 0.19% of shares | low |
| Jan 22, 2026 | Exercise | BCAX Bicara Therapeutics Inc. Stock Option (Right to Buy) | — | -2K -2.79% | 65,462 0.10% of shares | low |